Checkpoint Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Checkpoint Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2017 to Q3 2024.
  • Checkpoint Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 35.3 %, a 35.1% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 35.3 +9.17 +35.1% Sep 30, 2024
Q2 2024 30.3 -12.3 -28.9% Jun 30, 2024
Q1 2024 29.8 -37.4 -55.6% Mar 31, 2024
Q4 2023 22 -84.7 -79.4% Dec 31, 2023
Q3 2023 26.2 -132 -83.5% Sep 30, 2023
Q2 2023 42.6 -180 -80.8% Jun 30, 2023
Q1 2023 67.2 -251 -78.9% Mar 31, 2023
Q4 2022 107 -334 -75.8% Dec 31, 2022
Q3 2022 158 -471 -74.9% Sep 30, 2022
Q2 2022 222 -484 -68.5% Jun 30, 2022
Q1 2022 318 -274 -46.2% Mar 31, 2022
Q4 2021 440 -22.6 -4.88% Dec 31, 2021
Q3 2021 629 +234 +59.3% Sep 30, 2021
Q2 2021 706 +422 +149% Jun 30, 2021
Q1 2021 592 +335 +130% Mar 31, 2021
Q4 2020 463 +240 +108% Dec 31, 2020
Q3 2020 395 +208 +111% Sep 30, 2020
Q2 2020 284 +57.6 +25.4% Jun 30, 2020
Q1 2020 257 -15.1 -5.55% Mar 31, 2020
Q4 2019 223 -113 -33.7% Dec 31, 2019
Q3 2019 187 -214 -53.3% Sep 30, 2019
Q2 2019 226 -200 -46.9% Jun 30, 2019
Q1 2019 272 -199 -42.3% Mar 31, 2019
Q4 2018 336 -194 -36.6% Dec 31, 2018
Q3 2018 401 -290 -41.9% Sep 30, 2018
Q2 2018 426 -408 -49% Jun 30, 2018
Q1 2018 471 Mar 31, 2018
Q4 2017 529 Dec 31, 2017
Q3 2017 690 Sep 30, 2017
Q2 2017 834 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.